Records and reported status
Aug 6, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured f... Aug 6, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured fo... Aug 6, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured f... Aug 6, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured f... Aug 6, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-4... Aug 6, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, Manufactured ... Aug 6, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured ... Aug 6, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729... Aug 6, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, Rx Only, Manufactured f... Aug 6, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729... Aug 6, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-4... Aug 6, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for:... Jun 8, 2026 FDA drug enforcement
Subpotent Drug
Class II Reported ongoing
Distribution: US Nationwide.
Official source for Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for... Sep 16, 2025 FDA drug enforcement
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
Class II Reported ongoing
Distribution: Nationwide in the US
Official source for Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufacture... Jun 20, 2025 FDA drug enforcement
Subpotent Drug: Assay below the approved specification
Class II Reported ongoing
Distribution: Nationwide in the USA
Official source for Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 90-count bottle, Rx Only, Manufactured for:... Jun 20, 2025 FDA drug enforcement
Subpotent Drug: Assay below the approved specification
Class II Reported ongoing
Distribution: Nationwide in the USA
Official source for Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottle, Rx Only, Manufactured fo... Jun 20, 2025 FDA drug enforcement
Subpotent Drug: Assay below the approved specification
Class II Reported ongoing
Distribution: Nationwide in the USA
Official source for Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 90-count bottle, Rx Only, Manufactured for: ... Jun 20, 2025 FDA drug enforcement
Subpotent Drug: Assay below the approved specification
Class II Reported ongoing
Distribution: Nationwide in the USA
Official source for Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 1000-count bottle, Rx Only, Manufactured for... Jun 20, 2025 FDA drug enforcement
Subpotent Drug: Assay below the approved specification
Class II Reported ongoing
Distribution: Nationwide in the USA
Official source for Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottle, Rx Only, Manufactured f... Jun 20, 2025 FDA drug enforcement
Subpotent Drug: Assay below the approved specification
Class II Reported ongoing
Distribution: Nationwide in the USA
Official source for Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottle, Rx Only, Manufactured fo...
Reasons in these listed records Subpotent Drug Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range. Subpotent Drug: Assay below the approved specification These examples come from this result page and are not a ranking of every recall reason.
Checking Accord Healthcare, Inc. Is there a recall on accord healthcare, inc. right now? This archive contains 103 records, including 25 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Where can I find older records? Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.